Osstem Implant India Profile
Key Indicators
- Authorised Capital ₹ 19.50 Cr
as on 17-06-2024
- Paid Up Capital ₹ 18.49 Cr
as on 17-06-2024
- Company Age 18 Year, 9 Months
- Last Filing with ROC 31 Mar 2022
- Revenue 89.09%
(FY 2022)
- Profit 76.32%
(FY 2022)
- Ebitda 81.12%
(FY 2022)
- Net Worth -19.71%
(FY 2022)
- Total Assets 19.48%
(FY 2022)
About Osstem Implant India
The Corporate was formerly known as Osstem Implant India Private Limited 100% For. Sub. Co. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 19.50 Cr and a paid-up capital of Rs 18.49 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Osstem Implant India Private Limited India is Aarti Nabar as COMPANY SECRETARY. Jinjun Lee, Yongcheon Na, and Heewon Park serve as directors at the Company.
- CIN/LLPIN
U51398MH2006PTC236140
- Company No.
236140
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Mar 2006
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Osstem Implant India?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aarti Nabar  | Company Secretary | 20-Jun-2016 | Current |
Heewon Park  | Managing Director | 29-Feb-2024 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jinjun Lee | Additional Director | 22-Jun-2020 | Current |
| Yongcheon Na | Additional Director | 26-Feb-2020 | Current |
Financial Performance and Corporate Structure Insights of Osstem Implant India.
Osstem Implant India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 89.09% increase. The company also saw a substantial improvement in profitability, with a 76.32% increase in profit. The company's net worth observed a substantial decline by a decrease of 19.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Osstem Implant India?
In 2022, Osstem Implant India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Osstem Implant India?
Osstem Implant India has a workforce of 162 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Osstem Implant India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Osstem Implant India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
